Introduction
IL-22 is a member of an emerging family of cytokines that includes the interferons, IL-10, IL-19, IL-20, IL-22/ IL-TIF, IL-24/MDA-7, and IL-26/AK155. [1] [2] [3] [4] [5] [6] [7] IL-22 was discovered as a cytokine that is induced by IL-9 in mouse thymic lymphomas, T cells, and mast cell lines, and by ConA in splenocytes. 4 Although the physiological function of IL-22 is still elusive, administration of IL-22 to mice has been shown to induce the expression of acute phase proteins in the liver. 8 More recently, IL-22 was shown to induce pancreatitis-associated protein 1 in the pancreas. 9 Since lipopolysaccharide (LPS) injection induces IL-22 gene expression in mouse tissues, 8 it is very likely that IL-22 plays a role in the immune response to bacterial infection.
Human IL-22 and its functional receptor complex were recently identified. The latter consists of a novel a chain designated IL-22R and a b chain (CRF2-4) that is shared with the IL-10 receptor complex. 8, 10, 11 Human IL-22-binding protein, a soluble decoy receptor for IL-22, has also been discovered. [12] [13] [14] [15] The expression of IL-22R in humans seems to be restricted to certain organs, including the pancreas, intestine, kidney, and liver, whereas CRF2-4 appears to be constitutively and broadly expressed in a wide variety of organs and cell types, suggesting that the expression of IL-22R dictates the sites of action of IL-22. 9 IL-22R-binding protein has been found to be expressed primarily in the placenta, and at lower levels in other tissues including spleen and skin, 14, 15 suggesting that the activity of IL-22 is highly regulated in these organs. The cytoplasmic portion of human IL-22R harbors STAT1-and STAT3-binding motifs, and IL-22 induces activation of STATs in various cell lines. 10, 11 Recently, IL-22R was found to compose, together with IL-20b, an alternative receptor for IL-20 and IL-24, which is in addition to the IL-20/IL-24 receptor consisting of IL-29Ra and IL-20Rb. 16 Thus, it is very likely that IL-22R has unknown functions.
Here, to further elucidate the physiological functions of IL-22 and IL-22R, we isolated a cDNA encoding mouse IL-22R, and investigated the genomic structure of the mouse IL-22R gene and its expression.
Results and discussion
Cloning of mouse IL-22 receptor a chain cDNA We performed a tblastn search using the human IL-22R protein sequence as a query sequence against the Genome Survey Sequences database of GenBank. We found that the translated amino acid sequence of the terminal nucleotide sequence of the mouse genomic clone UUGC2M0106J11R (accession number AZ829180) in the antisense orientation was highly homologous to the query sequence. We performed 3 0 and 5 0 rapid amplification of cDNA ends (RACE) against poly(A) + RNA purified from the MES13 cell line using several primers whose design was based on the obtained nucleotide sequence. As a result, we obtained a 1746-bp nucleotide sequence containing the entire coding sequence of mouse IL-22R cDNA (Figure 1a) . The sequence was identical to that of mouse IL-22R cDNA amplified from mouse liver mRNA by RT-PCR, indicating its authenticity. A comparison of human and mouse IL-22R nucleotide and amino acid sequences revealed that their identity is 77.7% at the nucleotide level, and 71.9% at the amino acid level (Figure 1b ). All three putative N-glycosylation sites in the extracellular region are conserved between the two species. All four potential 
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Genomic sequence of the mouse IL-22R gene We performed a blast search using the entire mouse IL-22R coding sequence as a query against the HighThroughput Genomic Sequences database of GenBank. We identified the phase I HTGS of the RP23-110F21 mouse genomic DNA fragment, which is derived from chromosome 4 and contains the entire sequence of the mouse IL-22R genomic gene except for a 20-bp single gap in intron 6. RP23-110F21 was found to be located on a fingerprint clone map in a distal region of mouse chromosome 4, approximately 131.4 megabases apart from its centromere. As predicted, this region is syntenic with the human IL22R gene locus on chromosome 1p36.11. We also found that D4Mit134 sequence tagged site marker was assigned to RP23-110F21 by electric PCR, and the marker has been mapped at the position 62.3 cM on chromosome 4 on the Whitehead genetic linkage map. This position is reasonably close to the mouse IL-22R gene locus assigned above on the fingerprint clone map.
The genes for runt-related transcription factor 3, IL-22R, cannabinoids receptor 2, 5-hydroxytryptamine receptor 1D, and CDC42, were found in common in the syntenic regions of the two species in this order from the centromere.
Comparison between the cDNA and genomic sequences of mouse IL-22R revealed that the proteincoding region is split into seven exons (Figure 2a ). The splice donor site following after exon 2 is GC, which does not match the GT-AG rule (Figure 2b ). We confirmed this by determining the sequence of a 297-bp genomic fragment containing the corresponding splicing donor site that was derived from mouse tail DNA in our laboratory. All other splice donor and acceptor sites conformed to the GT-AG rule. Interestingly, all the splice donor and acceptor sites of the human IL-22R gene, including the splice donor site of exon 2, conformed to the GT-AG rule.
Comparison of the 5 0 flanking region of the human and mouse IL-22R genes indicated that the region up to 500 bp from the initiation ATG codon is conserved (Figure 2c ). Although there is no typical TATA-box sequence (TATAAA) in this region, an analysis using the Hamming-Clustering method for TATA signal (HCtata) program identified four candidates that had weak similarity to TATA-boxes. Therefore, we performed a similar analysis for the human IL-22R gene and found two TATA-box candidates. The comparison between the two species indicated that only the sequence found at around position À260 (where the translation initiation site is assigned as +1) is conserved. Therefore, we assume that this is a TATA-box (Figure 2c ). We also found multiple conserved transcription factor binding sites within the same 500-bp region using the MatInspector professional program. The possible binding elements include those for AP-1, GATA-binding factors, Sp-1, NFkB, and STAT ( Figure 2c) .
A putative poly(A) addition signal (TCAATGAAAT) was found 680 bases downstream of the stop codon of the mouse IL-22R gene, using the Hamming-Clustering method for ploy (A) additional signal (HCpolya) program. There is a homologous sequence (CAAAT-GAAAT) 875 bases downstream of the stop codon of the human IL-22R gene, which is also predicted to be a poly(A) addition signal by the same program. These data indicate that the predicted mouse IL-22R gene (from the putative TATA-box to the poly(A) addition signal) spans a region of about 24 kb and that the overall structure of the mouse IL-22R gene is strikingly similar to the human IL-22R gene structure.
IL-22R transduces the IL-22 signal
In humans, the functional receptor for IL-22 consists of IL-22R and CR2-4. To confirm that the isolated mIL-22R cDNA is a component of the functional IL-22R, a MES-13 cell line that expresses CR2-4 was transfected with the IL-22R cDNA in combination with a STAT1 or STAT3 reporter luciferase cDNA (Figure 3 ). Although we could amplify IL-22R cDNA from untransfected MES-13 cells, STAT1 and STAT3 activation was not detected in these cells when they were stimulated with recombinant mouse IL-22. However, transfection with IL-22R conferred IL-22 responsiveness on these cells. These results indicate that IL-22R expression is the limiting factor for the IL-22 responsiveness of MES-13 cells and that IL-22R transduces the IL-22 signal.
Expression of IL-22R mRNA in mice Expression of IL-22R mRNA in various tissues was investigated using Northern blot analysis. IL-22R mRNA was detected weakly in the liver and kidney (Figure 4a ). Since the expression of IL-22 mRNA is reportedly upregulated in the liver upon LPS stimulation in vivo, 8 we investigated expression of IL-22R mRNA in several tissues after the intraperitoneal injection of 2 mg of LPS. Expression of IL-22R was moderately and strongly increased in the liver at 4 and 8 h, respectively, after the LPS injection. In contrast, LPS did not significantly affect IL-22R expression in the kidney. To investigate simultaneously the expression of IL-22R and related genes before and after the LPS stimulation, we performed semiquantitative RT-PCR analyses (Figure 4b) . Consistent with the Northern blot analyses, IL-22R expression in the liver, but not the kidney, was upregulated after LPS stimulation. In addition, it appeared that the lung weakly expressed IL-22R mRNA constitutively, and the expression level was not affected by LPS. No IL-22R expression was observed in the spleen, heart, or brain. On the other hand, CR2-4 was expressed in all the tissues tested, and LPS did not affect the expression levels of CR2-4. IL-22 was constitutively but weakly expressed in all the tissues tested. Consistent with a previous report, 8 its expression was upregulated 4 h after the LPS injection in all the tested tissues except the brain. However, unlike the effect of LPS on IL-22R mRNA expression, the upregulation of IL-22 expression in response to LPS was transient, and it declined 8 h after the LPS injection. LPS did not affect IL-22 expression in the brain, probably because it did not cross the blood-brain barrier during the testing period.
Taken together, LPS coordinately induces the expression of both IL-22 and IL-22R in the liver. In contrast, the expression level of CR2-4 was unchanged after LPS stimulation. IL-22 induces expression of acute phase Figure 3 Mouse IL-22R cDNA confers responsiveness to IL-22. MES13 cells were transiently transfected with a tester plasmid (pEFmIL22R or the corresponding empty vector), a luciferase reporter plasmid (upper panel, pSTAT3-TA-Luc; lower panel, pGAS-TALuc), and a renilla luciferase internal control plasmid (pRL-TK). The cells were then cultured with medium supplemented to 10% with the culture supernatant from COS7 cells transfected with an expression vector harboring the mIL-22 cDNA or the empty vector (mock). Luciferase activity was monitored 6 h later. The results are expressed in arbitrary units that were standardized using the renilla luciferase internal control.
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A Tachiiri et al proteins in the liver. 8 Therefore, the responsiveness of hepatocytes to IL-22, and hence a part of the LPSinduced acute phase response, is controlled by the transcriptional levels of the IL-22R gene. Consistent with the responsiveness of the IL-22R gene to LPS, we found a putative binding site for NF-kB (Figure 2c) , which is the major transcription factor activated by LPS. We also found a possible STAT-binding site overlapping with the putative NF-kB site. Since IL-22R transduces the IL-22 signal into STAT activation, it is possible that IL-22R expression is upregulated by a signal that is transduced through IL-22R itself. Multiple GATA elements were found in the promoter region of the human and mouse IL-22R genes. These GATA elements may contribute to the tissue-specific expression of IL-22R. 18 IL-22R was recently shown to function as a component of an alternative receptor for IL-20 and IL-24, 16 suggesting that the IL-22R gene plays complex roles in vivo. Disruption of the mouse IL-22R gene in animals will provide further clues to understanding its physiological roles.
Materials and methods

Mice, cells, and reagents
Female BALB/c mice were purchased from SLC Inc. (Shizuoka, Japan) and used between 8 and 12 weeks of age. COS7 and MES-13 cells were cultured in DMEM (Sigma St Louis, MO, USA) containing 100 U/ml penicillin and 100 mg/ml streptomycin and supplemented with 10 and 5% FCS, respectively.
Web-based gene analysis programs Searches of nucleotide sequence databases for homologous nucleotide sequences to human IL-22R were performed using the tblastn program provided by the National Center for Biotechnology Information and available under http://www.ncbi.nlm.nih.gov/BLAST. Putative TATA-box and poly(A) additional signals were searched for using the HCtata and HCpolya programs provided by the Institute of Advanced Biomedical Technologies and available under http://www.itba.-mi.cnr.it/webgene. The search for possible transcriptional factor binding sites was performed using the MatInspector professional program 19 provided by Genomatix Software GmbH and available under http:// www.genomatix.de:80.
Cloning of cDNA
Based on the homologous nucleotide sequence to a part of the human IL-22R cDNA sequence found in the mouse genomic clone UUGC2M0106J11R, we designed a series of sense and antisense primers for 3 0 and 5 0 RACE. For the 3 0 RACE, poly(A) + RNA was prepared from the kidney of an LPS-stimulated mouse. The first strand cDNA was generated using an oligo dT primer connected to an adapter sequence (5 0 -GACTCGAGTCGA-CATCGA(T) 17 -3 0 ). The 3 0 end of the mouse IL-22R cDNA was then amplified using the mIL22RS1 sense primer (5 0 -CAAGACAAAAGGTCAGCTCC-3 0 ) and the adapter sequence (5 0 -GACTCGAGTCGACATCG-3 0 ) primer. The first round of 5 0 RACE was performed using the 5 0 -Full RACE Core Set (TAKARA, Otsu, Shiga, Japan) and LPSstimulated mouse liver poly(A) + RNA. Further rounds of 5 0 -RACE were performed using the 5 0 RACE System version 2.0 (Invitrogen, Carlsbad, CA, USA) and poly(A) + RNA prepared from MES13 cells, based on the newly determined nucleotide sequences of mouse IL-22R. A cDNA encoding the entire mouse IL-22R was generated from LPS-stimulated mouse liver poly(A) + RNA by RT-PCR using the mIL22RS7 sense primer (5 0 -CCCTGGAGGGACCCAATGAAGACAC-3 0 ) and the mIL22RA4 antisense primer (5 0 -CCTTCAGGATTCC-CACTGCA-3 0 ). Mouse IL-22 cDNA was generated from ConAactivated mouse spleen cell poly(A) + RNA using a sense primer (5 0 -CACTTATCAACTGTTGACAC-3 0 ) and an antisense primer (5 0 -GTTTTCTAGCTTCTTCTCGC-3 0 ). The cDNA generated by PCR was inserted into the pMOSBlue vector using a pMOSBlue blunt-ended cloning kit (Amersham Biosciences, Piscataway, NJ, USA), and the nucleotide sequence was determined using a CEQ2000 Dye Terminator Cycle Sequencing with Quick Start Kit and a CEQ 2000 DNA Analysis System (BECKMAN COULTER, Fullerton, CA, USA). The EcoRIXbaI fragment containing mouse IL-22R cDNA and the KpnI-NheI fragment containing mouse IL-22 cDNA were excised from pMOS-IL22R and pMOS-mIL22, and ligated between the corresponding sites of the mammalian expression vector pEF-BOS-EX 20 to generate pEF-mIL22R and pEF-mIL22, respectively.
Preparation of recombinant mouse IL-22 COS7 cells were transiently transfected with pEF-mIL22 using a modification of the DEAE-dextran method. 21 In brief, COS7 cells in a 10-cm dish at about 50% confluence were washed with DMEM containing 50 mM Tris-HCl Cloning and expression of mouse IL-22R gene A Tachiiri et al (pH 7.4) and incubated with the same medium containing 0.3 mg/ml DEAE-dextran, 0.15 mM chloroquine, and 5 mg plasmid DNA for 4 h at 371C in a 5% CO 2 atmosphere. Cells were then treated with Tris-buffered saline containing 15% glycerol for 2 min, immediately washed with DMEM, and cultured with 10% FCS-DMEM. The medium was replaced with fresh 10% FCS-DMEM 20 h later, and the cells were cultured for a further 3 days. The culture supernatant was used as a source of mouse IL-22. The culture supernatant from COS7 cells transfected with the pEF-BOS-EX vector was used as a control.
Assays for the transcriptional activity of STATs MES13 cells (2 Â 10 5 cells) were transfected with 0.3 mg tester plasmid (pEF-IL22R or pEF-BOS-EX) together with 0.05 mg reporter plasmid (pGAS-TA-Luc or pSTAT3-TALuc, Mercury JAK/STAT Pathway proliferating System, CLONTECH, Palo Alto, CA, USA), and 0.05 mg internal control plasmid, pRL-TK (Promega, Madison, WI, USA), using lipofectamine (Invitrogen) according to the manufacturer's protocol. pGAS-TA-Luc contains five IFNg activation sequences, and pSTAT3-TA-Luc contains STAT3-binding sequences; these elements are inserted upstream of a luciferase gene controlled by the thymidine kinase promoter. In all, 24-48 h after the transfection, cells were stimulated for 6 h in medium supplemented to 10% with the culture supernatant from COS7 cells transfected with either pEF-mIL22 or the empty vector. The cells were then lysed and their luciferase activity was determined using a Dual-Luciferase Reporter Assay System kit (Promega).
Northern blot and RT-PCR analyses
Total RNA was extracted from tissues using the TRIzol Reagent (Invitrogen). Poly(A) + RNA was then purified from the total RNA using a QuickPrep Micro mRNA Purification Kit (Amersham Biosciences). Northern blot analyses were performed as described, 22 except that the Rapid-hyb buffer (Amersham Biosciences) supplemented with 200 mg/ml alkali-denatured herring sperm DNA was used as the hybridization buffer. The 1.7-kb PCR fragment of mouse IL-22R cDNA (sense primer, mIL22RS7; antisense primer, mIL22RA4) and the 240-bp PCR fragment of mouse b-actin cDNA (mbactinS1 sense primer, 5 0 -TGCGTGACATCAAAGAGAAG-3 0 ; mbactinA1 antisense primer, 5 0 -CGGATGTCAACGTCA-CACTT-3 0 ) were labeled with 32 P using a Prime-It II Random Primer Labeling Kit (STRATAGENE, La Jolla, CA, USA) and used as probes.
For semiquantitative RT-PCR analyses, single-strand cDNA templates were prepared from 1 mg poly(A) + RNA from various tissues using Superscript II reverse transcriptase (Invitrogen). Specific cDNAs were then amplified by PCR using the following primers and conditions: mouse IL-22, sense primer 5 0 -CACTTATCAACTGTTGA-CAC-3 0 , antisense primer 5 0 -GTTTTCTAGCTTCTTCTC-GC-3 0 , annealing temperature (T a ) 601C, 38 cycles; mCR2-4, sense primer 5 0 -ACATGGCCCCGTGCGTGGCG-3 0 , antisense primer 5 0 -GCTCTCTGGTCATACTTCTG-3 0 , T a 601C, 26 cycles; mouse IL-22R, sense primer 5 0 -CTGCAACCTGACTATGGAGA-3 0 , antisense primer 5 0 -TTCACTCGGCACACGTAGGG-3 0 , T a 601C, 27 cycles; mouse b-actin, sense primer 5 0 -TGCGTGACATCAAA-GAGAAG-3, antisense primer 5 0 -CGGATGTCAACGT-CACACTT-3 0 , T a 601C, 17 cycles. The amounts of the template cDNA were normalized so that a similar amount of a PCR fragment of b-actin was generated within the linear range of the PCR reaction.
